U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07470502) titled 'MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease' on March 10.
Brief Summary: This is a monocentric, non-profit prospective cohort study with longitudinal biological sampling. The study will include patients with IBD starting biological therapy with infliximab. During four routine clinical visits in the induction phase (standard or accelerated) and the first maintenance visit, two saliva samples (pre- and post-infusion) and one plasma sample (pre-infusion) will be collected. Plasma samples will be obtained from leftover blood collected during routine clinical practice, with no additional blood draws required. The ...